VIVA BIOTECH (01873) Income Statement & Earnings

1.680
+0.010+0.60%

Not Open Apr 30 15:58 CST

3.58BMarket Cap14.74P/E (TTM)

VIVA BIOTECH (01873) Income Statement

All

YOY

Hide blank lines

(FY)Dec 31, 2025

(Q6)Jun 30, 2025

(FY)Dec 31, 2024

(Q6)Jun 30, 2024

(FY)Dec 31, 2023

(Q6)Jun 30, 2023

(FY)Dec 31, 2022

(Q6)Jun 30, 2022

(FY)Dec 31, 2021

(Q6)Jun 30, 2021

Turnover

-12.95%1.73B

-15.27%831.87M

-7.84%1.99B

-14.04%981.82M

-9.42%2.16B

3.02%1.14B

13.10%2.38B

8.02%1.11B

201.90%2.1B

419.57%1.03B

Operating income

-12.95%1.73B

-15.27%831.87M

-7.84%1.99B

-14.04%981.82M

-9.42%2.16B

3.02%1.14B

13.10%2.38B

8.02%1.11B

201.90%2.1B

419.57%1.03B

Cost of sales

17.35%-1.07B

23.38%-492.45M

8.32%-1.3B

12.71%-642.68M

9.39%-1.42B

3.61%-736.22M

-7.63%-1.56B

-7.55%-763.78M

-270.60%-1.45B

-628.84%-710.18M

Operating expenses

17.35%-1.07B

23.38%-492.45M

8.32%-1.3B

12.71%-642.68M

9.39%-1.42B

3.61%-736.22M

-7.63%-1.56B

-7.55%-763.78M

-270.60%-1.45B

-628.84%-710.18M

Gross profit

-4.63%655.56M

0.08%339.43M

-6.91%687.4M

-16.46%339.15M

-9.47%738.43M

17.68%405.97M

25.30%815.68M

9.07%344.97M

113.53%650.98M

215.90%316.28M

Selling expenses

9.91%-101.11M

-0.21%-57.68M

15.33%-112.23M

20.54%-57.56M

-1.33%-132.55M

-29.57%-72.44M

-39.19%-130.8M

-61.04%-55.91M

-617.63%-93.97M

-1,679.40%-34.72M

Administrative expenses

-4.33%-262.8M

-7.53%-126.04M

9.10%-251.89M

10.80%-117.21M

-1.26%-277.11M

7.79%-131.4M

-20.92%-273.65M

-41.94%-142.5M

-105.43%-226.31M

-170.98%-100.39M

Research and development expenses

-14.17%-100.46M

5.83%-40.33M

31.24%-87.99M

44.16%-42.83M

5.79%-127.97M

-87.45%-76.7M

-47.04%-135.84M

-9.18%-40.92M

-39.89%-92.38M

-67.87%-37.48M

Revaluation surplus

79.80%150.54M

-18.40%52.58M

-48.52%83.73M

353.17%64.43M

145.93%162.64M

238.90%14.22M

-293.35%-354.13M

-117.28%-10.24M

71.26%183.15M

-11.11%59.25M

-Changes in the fair value of financial assets

79.80%150.54M

-18.40%52.58M

816.73%83.73M

353.17%64.43M

96.79%-11.68M

238.90%14.22M

-897.31%-364.18M

-117.28%-10.24M

-57.29%45.68M

-11.11%59.25M

-Changes in the fair value of other assets

----

1,634.56%174.32M

----

-92.69%10.05M

----

--137.48M

----

Impairment and provision

136.61%2.06M

109.00%422K

30.81%-5.62M

-743.71%-4.69M

13.65%-8.13M

88.57%-556K

-566.03%-9.41M

-4,482.88%-4.87M

53.35%-1.41M

125.58%111K

-Other impairment is provision

136.61%2.06M

109.00%422K

30.81%-5.62M

-743.71%-4.69M

13.65%-8.13M

88.57%-556K

-566.03%-9.41M

-4,482.88%-4.87M

53.35%-1.41M

125.58%111K

Operating interest expense

----

7.28%-89.1M

----

---96.1M

Special items of operating profit

-55.30%16.22M

-37.45%22.25M

115.46%36.3M

347.77%35.58M

-25.95%-234.7M

80.85%-14.36M

-268.24%-186.34M

-363.39%-74.97M

225.95%110.76M

5.31%28.47M

Operating profit

2.95%360.02M

-12.10%190.63M

189.89%349.69M

73.86%216.87M

143.95%120.63M

269.65%124.74M

-151.71%-274.49M

-154.29%-73.52M

177.44%530.81M

2.55%135.42M

Financing cost

30.38%-37.52M

40.95%-18.51M

69.48%-53.89M

64.37%-31.35M

4.38%-176.58M

---87.98M

-0.86%-184.67M

----

---183.11M

----

Share of profits of associates

-4,633.68%-4.5M

---418K

---95K

----

Special items of earning before tax

----

175.19%10.05M

----

97.83%-13.37M

Earning before tax

7.54%318M

-7.45%171.7M

628.49%295.71M

404.78%185.52M

87.81%-55.95M

157.90%36.75M

-232.06%-459.17M

-152.00%-63.47M

197.61%347.7M

123.36%122.05M

Tax

33.89%-48.74M

44.14%-23.06M

-68.16%-73.72M

-78.75%-41.28M

2.70%-43.84M

-6.19%-23.09M

4.43%-45.06M

17.16%-21.75M

-108.04%-47.14M

-233.19%-26.25M

After-tax profit from continuing operations

21.30%269.27M

3.05%148.64M

322.45%221.99M

955.99%144.24M

80.21%-99.79M

116.03%13.66M

-267.76%-504.22M

-188.95%-85.22M

179.33%300.56M

118.07%95.8M

Earning after tax

21.30%269.27M

3.05%148.64M

322.45%221.99M

955.99%144.24M

80.21%-99.79M

116.03%13.66M

-267.76%-504.22M

-188.95%-85.22M

179.33%300.56M

118.07%95.8M

Minority profit

-9.48%49.51M

-2.18%26.83M

235.07%54.69M

116.90%27.43M

-32.70%16.32M

111.44%12.65M

86.38%24.26M

-44.53%5.98M

62.47%13.01M

--10.78M

Profit attributable to shareholders

31.36%219.76M

4.28%121.81M

244.08%167.29M

11,430.90%116.81M

78.03%-116.11M

101.11%1.01M

-283.79%-528.48M

-207.27%-91.2M

174.32%287.55M

116.03%85.02M

Basic earnings per share

25.00%0.1

20.00%0.06

233.33%0.08

4,900.00%0.05

78.57%-0.06

102.00%0.001

-286.67%-0.28

-225.00%-0.05

160.00%0.15

110.53%0.04

Diluted earnings per share

50.00%0.09

0.00%0.05

142.86%0.06

4,900.00%0.05

50.00%-0.14

102.00%0.001

-450.00%-0.28

-225.00%-0.05

132.00%0.08

110.53%0.04

Currency Unit

CNY

Accounting Standards

IAS

Audit Opinions

Unqualified Opinion

Auditor

Ernst & Young

	(FY)Dec 31, 2025	(Q6)Jun 30, 2025	(FY)Dec 31, 2024	(Q6)Jun 30, 2024	(FY)Dec 31, 2023	(Q6)Jun 30, 2023	(FY)Dec 31, 2022	(Q6)Jun 30, 2022	(FY)Dec 31, 2021	(Q6)Jun 30, 2021
Turnover	-12.95%1.73B	-15.27%831.87M	-7.84%1.99B	-14.04%981.82M	-9.42%2.16B	3.02%1.14B	13.10%2.38B	8.02%1.11B	201.90%2.1B	419.57%1.03B
Operating income	-12.95%1.73B	-15.27%831.87M	-7.84%1.99B	-14.04%981.82M	-9.42%2.16B	3.02%1.14B	13.10%2.38B	8.02%1.11B	201.90%2.1B	419.57%1.03B
Cost of sales	17.35%-1.07B	23.38%-492.45M	8.32%-1.3B	12.71%-642.68M	9.39%-1.42B	3.61%-736.22M	-7.63%-1.56B	-7.55%-763.78M	-270.60%-1.45B	-628.84%-710.18M
Operating expenses	17.35%-1.07B	23.38%-492.45M	8.32%-1.3B	12.71%-642.68M	9.39%-1.42B	3.61%-736.22M	-7.63%-1.56B	-7.55%-763.78M	-270.60%-1.45B	-628.84%-710.18M
Gross profit	-4.63%655.56M	0.08%339.43M	-6.91%687.4M	-16.46%339.15M	-9.47%738.43M	17.68%405.97M	25.30%815.68M	9.07%344.97M	113.53%650.98M	215.90%316.28M
Selling expenses	9.91%-101.11M	-0.21%-57.68M	15.33%-112.23M	20.54%-57.56M	-1.33%-132.55M	-29.57%-72.44M	-39.19%-130.8M	-61.04%-55.91M	-617.63%-93.97M	-1,679.40%-34.72M
Administrative expenses	-4.33%-262.8M	-7.53%-126.04M	9.10%-251.89M	10.80%-117.21M	-1.26%-277.11M	7.79%-131.4M	-20.92%-273.65M	-41.94%-142.5M	-105.43%-226.31M	-170.98%-100.39M
Research and development expenses	-14.17%-100.46M	5.83%-40.33M	31.24%-87.99M	44.16%-42.83M	5.79%-127.97M	-87.45%-76.7M	-47.04%-135.84M	-9.18%-40.92M	-39.89%-92.38M	-67.87%-37.48M
Revaluation surplus	79.80%150.54M	-18.40%52.58M	-48.52%83.73M	353.17%64.43M	145.93%162.64M	238.90%14.22M	-293.35%-354.13M	-117.28%-10.24M	71.26%183.15M	-11.11%59.25M
-Changes in the fair value of financial assets	79.80%150.54M	-18.40%52.58M	816.73%83.73M	353.17%64.43M	96.79%-11.68M	238.90%14.22M	-897.31%-364.18M	-117.28%-10.24M	-57.29%45.68M	-11.11%59.25M
-Changes in the fair value of other assets	----	----	----	----	1,634.56%174.32M	----	-92.69%10.05M	----	--137.48M	----
Impairment and provision	136.61%2.06M	109.00%422K	30.81%-5.62M	-743.71%-4.69M	13.65%-8.13M	88.57%-556K	-566.03%-9.41M	-4,482.88%-4.87M	53.35%-1.41M	125.58%111K
-Other impairment is provision	136.61%2.06M	109.00%422K	30.81%-5.62M	-743.71%-4.69M	13.65%-8.13M	88.57%-556K	-566.03%-9.41M	-4,482.88%-4.87M	53.35%-1.41M	125.58%111K
Operating interest expense	----	----	----	----	----	----	----	7.28%-89.1M	----	---96.1M
Special items of operating profit	-55.30%16.22M	-37.45%22.25M	115.46%36.3M	347.77%35.58M	-25.95%-234.7M	80.85%-14.36M	-268.24%-186.34M	-363.39%-74.97M	225.95%110.76M	5.31%28.47M
Operating profit	2.95%360.02M	-12.10%190.63M	189.89%349.69M	73.86%216.87M	143.95%120.63M	269.65%124.74M	-151.71%-274.49M	-154.29%-73.52M	177.44%530.81M	2.55%135.42M
Financing cost	30.38%-37.52M	40.95%-18.51M	69.48%-53.89M	64.37%-31.35M	4.38%-176.58M	---87.98M	-0.86%-184.67M	----	---183.11M	----
Share of profits of associates	-4,633.68%-4.5M	---418K	---95K	----	----	----	----	----	----	----
Special items of earning before tax	----	----	----	----	----	----	----	175.19%10.05M	----	97.83%-13.37M
Earning before tax	7.54%318M	-7.45%171.7M	628.49%295.71M	404.78%185.52M	87.81%-55.95M	157.90%36.75M	-232.06%-459.17M	-152.00%-63.47M	197.61%347.7M	123.36%122.05M
Tax	33.89%-48.74M	44.14%-23.06M	-68.16%-73.72M	-78.75%-41.28M	2.70%-43.84M	-6.19%-23.09M	4.43%-45.06M	17.16%-21.75M	-108.04%-47.14M	-233.19%-26.25M
After-tax profit from continuing operations	21.30%269.27M	3.05%148.64M	322.45%221.99M	955.99%144.24M	80.21%-99.79M	116.03%13.66M	-267.76%-504.22M	-188.95%-85.22M	179.33%300.56M	118.07%95.8M
Earning after tax	21.30%269.27M	3.05%148.64M	322.45%221.99M	955.99%144.24M	80.21%-99.79M	116.03%13.66M	-267.76%-504.22M	-188.95%-85.22M	179.33%300.56M	118.07%95.8M
Minority profit	-9.48%49.51M	-2.18%26.83M	235.07%54.69M	116.90%27.43M	-32.70%16.32M	111.44%12.65M	86.38%24.26M	-44.53%5.98M	62.47%13.01M	--10.78M
Profit attributable to shareholders	31.36%219.76M	4.28%121.81M	244.08%167.29M	11,430.90%116.81M	78.03%-116.11M	101.11%1.01M	-283.79%-528.48M	-207.27%-91.2M	174.32%287.55M	116.03%85.02M
Basic earnings per share	25.00%0.1	20.00%0.06	233.33%0.08	4,900.00%0.05	78.57%-0.06	102.00%0.001	-286.67%-0.28	-225.00%-0.05	160.00%0.15	110.53%0.04
Diluted earnings per share	50.00%0.09	0.00%0.05	142.86%0.06	4,900.00%0.05	50.00%-0.14	102.00%0.001	-450.00%-0.28	-225.00%-0.05	132.00%0.08	110.53%0.04
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	IAS	IAS	IAS	IAS	IAS	IAS	IAS	IAS	IAS	IAS
Audit Opinions	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion	--	--	--	Unqualified Opinion	--
Auditor	Ernst & Young	--	Ernst & Young	--	Ernst & Young	--	Ernst & Young	--	Ernst & Young	--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More

牛牛課堂

Oct 13, 2025 18:05

[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?

Food流油

Apr 14, 2025 15:43

"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"